Current Issue December 2011, Vol. 1, No. 1

Issue Highlights

Review Articles

  • Implication of nuclear EGFR in the development of resistance to anticancer therapies
    December 2011(Vol. 1 | No. 1 | Pages 2-10)

    Wei-Chien Huang, Yun-Ju Chen, Mien-Chie Hung

  • Activation of Toll-like receptors induces macrophage migration via the iNOS/Src/FAK pathway
    December 2011(Vol. 1 | No. 1 | Pages 11-15)

    Ming-Chei Maa, Tzeng-Horng Leu

  • P2X7 receptor as a double-edged sword: Neurotrophic and neurotoxic effects
    December 2011(Vol. 1 | No. 1 | Pages 16-20)

    Yuk-Man Leung

  • Molecular mechanisms of chondrosarcoma metastasis
    16 February 2012

    Chih-Hsin Tang

  • An overview of dna microarray analysis as a tool to investigate the therapeutic mechanisms and drug development of chinese medicinal herbs
    13 February 2012

    Chia-Cheng Li, Hsin-Yi Lo, Chien-Yun Hsiang, Tin-Yun Ho

  • Biomedicine offers advanced medical findings
    10 February 2012

    Mei-chin Yin

  • Possible pathophysiology of heart failure in obesity: Cardiac apoptosis
    23 December 2011

    Chih-Yang Huang, Shin-Da Lee

  • Angelica sinensis: A Chinese herb for brain cancer therapy
    21 December 2011

    Po-Cheng Lin, Po-Yen Liu, Shinn-Zong Lin, Horng-Jyh Harn

  • View More Articles in Press...

On the Cover

Cover Image

Journal Access

Full-text articles are available from 2011 to the present. Access to abstracts is complimentary. Access to full text is limited to Society Name members as well as personal subscribers.

Activate Online Access

Publishing Information

BioMedicine is published by Elsevier for the China Medical University.

 
Access this journal onSciVerse ScienceDirect
Print or Share This Page

About BioMedicine

BioMedicine is a peer-reviewed journal that aims to publish high quality scientific research in the field of translational and personalized medicine, with the goal of promoting and disseminating medical science knowledge to improve global health. It is published quarterly by Elsevier.

Articles on clinical, laboratory and social research in translational and personalized medicine and other related fields that are of interest to the medical profession are eligible for consideration. Review articles, original articles, case reports, short communications, and letters to the editor are accepted.

About China Medical University

China Medical University (CMU) was first established as China Medical College on June 6, 1958 and was upgraded into China Medical University in 2003. It is the first academic institution in Taiwan where Chinese medicine and pharmacy programs are provided. The university has steadily grown to its present position as one of the foremost medical universities in Taiwan. Located in the center of Taichung City, CMU is composed of 6 colleges covering western medicine, Chinese medicine, pharmacy (including Chinese herbs), health care (including nursing), life sciences, and public health educational, research and practice programs. Interdisciplinary courses are also available as the basis for students to integrate their learning experiences.